← Back to Search

acupressure intervention for Breast Cancer

N/A
Waitlist Available
Led By Judy Wang, Ph.D.
Research Sponsored by Georgetown University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 8 weeks post-intervention
Awards & highlights

Study Summary

This study develops and pilot tests the efficacy of a home-based, self-administered acupressure intervention in improving cancer-related fatigue (proximal outcome), and physical functioning and other quality of life outcomes (distal outcomes) of Chinese immigrant breast cancer survivors (versus usual care control group).

Eligible Conditions
  • Breast Cancer

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~8 weeks post-intervention
This trial's timeline: 3 weeks for screening, Varies for treatment, and 8 weeks post-intervention for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Cancer-related fatigue (proximal outcome)
Secondary outcome measures
Anxiety
Depression
Pain interference
+2 more

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: acupressure interventionExperimental Treatment1 Intervention
Practice acupressure at home and complete daily logs
Group II: usual carePlacebo Group1 Intervention
Receive usual care and complete daily logs

Find a Location

Who is running the clinical trial?

Georgetown UniversityLead Sponsor
343 Previous Clinical Trials
136,378 Total Patients Enrolled
33 Trials studying Breast Cancer
12,961 Patients Enrolled for Breast Cancer
Judy Wang, Ph.D.Principal InvestigatorGeorgetown University
2 Previous Clinical Trials
621 Total Patients Enrolled
1 Trials studying Breast Cancer
141 Patients Enrolled for Breast Cancer

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~14 spots leftby Apr 2025